Nuformix - Overview

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. We use our expertise in discovering, developing and patenting novel drug forms with improved physical properties, to develop new products in new indications that are differentiated from the original by way of: dosage, delivery route or presentation, thus creating new and attractive commercial opportunities.

Competitors: Hemogenyx Pharmaceuticals
Registrars:

Key Personnel

Executive Director: Daniel Gooding
Non-Executive Chairman: Julian Gilbert
Independent Non-Executive Director: Madeleine Kennedy

Contact Details

Address: 6th Floor, 60 Gracechurch Street, London, United Kingdom
Phone: +44 (0)1223 627222
Fax:
Website: https://nuformix.com/
Email:

Listings

ISIN: GB00BYW79Y38
Sector: Pharma and Biotech, Pharma and Biotech